构建 PANoptosis 签名:为前列腺癌免疫治疗发现了新的点

Xianyanling Yi1, Jin Li1, Xiaonan Zheng1

  • 1Department of Urology, Institute of Urology, West China Hospital, Sichuan University, 88 South Keyuan Road, Chengdu 610041, China.

概括

一个新的PANoptosis签名准确地预测前列腺腺癌 (PRAD) 的预后和免疫治疗反应. 获得高分数的患者表现出更好的生存率和增强的抗瘤免疫力,识别出新的治疗点.